The Tcr-based Therapy Market Is Projected To Grow At An Annualized Rate Of 51%
February 6, 2023 ⚊ 1 Min read ⚊ Views 71 ⚊ HEALTH
Given the recent approval of a TCR-based therapy, industry stakeholders have initiated several R&D efforts focused on evaluating the potential of such therapy candidates against various disease indications. Modified T-cell receptor therapy (TCR therapy) is an emerging class of adoptive therapy that employs genetically modified lymphocytes to target specific tumor markers.
Tags: Global TCR-based Therapy Market, T-cell receptor
